Ketamine-inspired nasal spray for depression on cusp of landmark FDA approval

A new nasal spray for depression, utilizing a novel drug called esketamine, has passed the last step on its way to final FDA approval. An advisory panel to the Food and Drug Administration (FDA) voted in favor of the new drug's risk/benefit profile meaning the ketamine-inspired treatment may be finally approved for clinical use within the next month.

.. Continue Reading Ketamine-inspired nasal spray for depression on cusp of landmark FDA approval

Category: Medical

Tags:

• Depression
• Ketamine
• Psychedelic Medicine
• Psychology

from New Atlas (Gizmag) http://bit.ly/2IjEndg